External open innovation partnering program: Zealand Pharma - Biowebspin | Biowebspin
Logo Biowebspin

Biowebspin : THE #1 ACADEMIA-INDUSTRY PARTNERING NETWORK IN LIFE SCIENCES

The worldwide platform to find industrial partners and funding

External open innovation partner programNovel complement-based inhibitory peptides for the treatment of rare diseases

Are you working on the complement system? Have you identified peptides that target the modulation of this innate immune system? Are you looking for industrial collaboration or funding?
What we are looking for

Part of the innate immune defense, the complement system plays a significant role in human physiology and disease, not only confined to the elimination of infectious pathogens and immune complexes. Complement is normally carefully regulated so it targets only unwanted materials and does not attack the body’s healthy cells. However, excessive or dysregulated complement activation contributes to many inflammatory, autoimmune and degenerative diseases.

We are looking for peptides that inhibit complement activation in orphan or rare diseases or niche indication.

What we offer

All proposals will be assessed by our Research & Development team. Based on the level of interest within our research portfolio and the strategic fit of the proposals into Zealand Pharma long-term research focus, we will enter into discussion with selected candidate(s), potentially leading to funding and partnership agreements.

Proponents that submit proposals of interest will be contacted within 6 weeks of submission to clarify additional details concerning the underlying science as well as intellectual property rights, timelines, etc

What to submit

Submit your proposal online (it takes about 15 minutes) in a form and length that is sufficient to provide the substance of the proposal and its innovativeness. The applicant should also provide information about his or her critical knowledge that is applicable for the project and how that knowledge could be supplemented (i.e., what is additionally required to complete the project).

Privacy, confidentiality & FAQ
Zealand Pharma

While Zealand Pharma will not share the information beyond its own staff, your initial proposal should contain only non-confidential information.
If your proposal is selected, you will be requested to complete a Confidentiality Disclosure Agreement (CDA).

Biowebspin

Biowebspin pays a lot of attention to the privacy, intellectual property, confidentiality and security of its member data.

Biowebspin is a matchmaking platform between academia & industry. Biowebspin is not involved in the IP discussion and is not charging any success or license fees. Your «Open Innovation» opportunities on Biowebspin are only visible by industrials and the Biowebspin team. You can remove your data at any time. Biowebspin strongly recommends that you do not enter any confidential data or if you do so, that your technology transfer office agrees the submission of your pre-proposal on Biowebspin. If you directly submit your pre-proposal on an industrial partner website, you will agree their terms, conditions and privacy policy of our industrial partner website. Biowebspin is not responsible for the content, accuracy, or opinion of its industrial partner website. As a Swiss International company, Biowebspin has high standard security and privacy system. Biowebspin is in accordance with the Federal Data Protection and Information Commissioner. Check here the terms and conditions of the matchmaking service of Biowebspin.

Zealand Pharma A/S

Zealand Pharma A/S (110 employees, based in Copenhagen) is a biotech company with leading-edge scientific expertise in turning peptides into revolutionary medicines that improve people’s lives. This mission is achieved through internal innovation, and collaboration with leading healthcare companies, academic institutions and biotechnology companies.

About Biowebspin:

Biowebspin is the leading life sciences network with more than 2 million researchers in Biotech, Pharma and Medtech. Biowebspin has a database of 50,000 companies working on 5000 different R&D projects in more than 50 topics, organized in 8 main types of partnering programs with Academia.

Check if one program will fit your researches for industrial collaboration and funding